Organisation paid for research Program year 2024 Source: CMS Open Payments

Reid Health

Neither a doctor nor a teaching hospital

Research payments

$102,298

6 payments

Through program year 2024, Reid Health is reported as receiving $102,298 in research payments, across 6 payments.

By program year

3 rows
Year Kind Amount Payments
2024 Research $95,874 3
2022 Research $4,074 2
2019 Research $2,350 1

Breakdown

Who paid Research payments · program years 2019–2024
  1. Boehringer Ingelheim International GmbH $70,670 4 payments
  2. Boehringer Ingelheim Pharma GmbH & Co.KG $29,277 1 payment
  3. AstraZeneca Pharmaceuticals LP $2,350 1 payment
Studies the money was for Research payments · program years 2019–2024
  1. BI 690517+Empa - Placebo+Empa in patients w. HF (LVEF) $95,874 3 payments
  2. Empagliflozin and Heart failure HFrEF $4,074 2 payments
  3. Upstream Ticagrelor Registry Study $2,350 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record